Journals / Neurological sciences and neurophysiology (Online) / 2019 / Cilt: 36 - Sayı: 1

Etiology, treatment, and outcomes of status epilepticus episodes in the elderly

Pages
22–27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Prolonged SE duration and the refractoriness of SE episodes are risk factors for poor outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Status epilepticus (SE) can cause life-threatening consequences.
📊
Key Findings & Data:Based on our databank, these factors were evaluated in patients aged over 60 years.
💡
Conclusion & Impact:Conclusion: Prolonged SE duration and the refractoriness of SE episodes are risk factors for poor outcomes.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Status epilepticus (SE) can cause life-threatening consequences. It is important to determine the etiologic factors of SE and treatment responses in elderly individuals, especially those with certain comorbidities. Based on our databank, these factors were evaluated in patients aged over 60 years. Methods: We reviewed the data of individuals aged over 60 years who were diagnosed clinically and electrophysiologically as having SE in the same databank. Demographic data of patients, SE subtypes, etiology, treatment responses, and survival of patients were noted. Results: We evaluated 162 patients aged older than 60 years with SE episodes. The mean age of the patients was 73 years. Seventy-three percent of the patients were female. The types of SE episodes were: nonconvulsive (NCSE) (93 episodes), convulsive SE (56 episodes), and NCSE after convulsive SE (23 episodes). Stroke was the leading cause of the etiologies and accounted for 37% of the SE episodes. The NCSE subtype was more refractory to treatment (p=0.003). The longer duration and refractoriness of the episodes significantly predicted a worse outcome (p=0.0001, p=0.01). Conclusion: Prolonged SE duration and the refractoriness of SE episodes are risk factors for poor outcomes.

🔖

Cite This Article

SÜNTER, G., AĞAN, K., MİDİ, İ., BİNGÖL, C. A. (2019). Etiology, treatment, and outcomes of status epilepticus episodes in the elderly. Neurological sciences and neurophysiology (Online), Cilt: 36 - Sayı: 1, 22–27. https://ajindex.com/articles/290543

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998
  2. [CrossRef] 2. Towne AR. Epidemiology and outcomes of status epilepticus in the elderly. Int Rev Neurobiol 2007
  3. [CrossRef] 3. De Lorenzo RJ, Hauser WA, Towne AR, et al. A prospective, pop-ulation-based epidemiologic study of status epilepticus in Rich-mond, Virginia. Neurology 1996
  4. [CrossRef] 4. Lowenstein DH, Bleck T, Macdonald RL. It’s time to revise the definition of status epilepticus. Epilepsia 1999
  5. [CrossRef] 5. Cascino GD, Hesdorffer D, Logroscino G, Hauser WA. Morbidity of nonfebrile status epilepticus in Rochester, Minnesota, 1965-1984. Epilepsia 1998
  6. [CrossRef] 6. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epi-lepsia 1993
  7. [CrossRef] 7. Ozdilek B, Midi I, Agan K, Bingol CA. Episodes of status epilepti-cus in young adults: etiologic factors, subtypes, and outcomes. Epilepsy Behav 2013
  8. [CrossRef] 8. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veter-ans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998
  9. [CrossRef] 9. Trinka E, Kälviäinen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure 2017
  10. [CrossRef] 10. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012
  11. [CrossRef] 11. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitz-simmons BF. Refractory status epilepticus: frequency, risk fac-tors, and impact on outcome. Arch Neurol 2002
  12. [CrossRef] 12. Bleck TP. Refractory status epilepticus. Curr Opin Crit Care 2005
  13. [CrossRef] 13. Sung CY, Chu NS. Status epilepticus in the elderly: etiology, seizure type and outcome. Acta Neurol Scand 1989
  14. [CrossRef] 14. Kaplan PW. Assessing the outcomes in patients with noncon-vulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 1999
  15. [CrossRef] 15. Kaplan PW. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist 2005
  16. [CrossRef] 16. Canouï-Poitrine F, Bastuji-Garin S, Alonso E, et al. Risk and prog-nostic facto